首页    期刊浏览 2025年12月04日 星期四
登录注册

文章基本信息

  • 标题:Scientific Opinion on the substantiation of a health claim related Immunofortis® and strengthening of the baby's immune system pursuant to Article 14 of Regulation (EC) No 1924/2006
  • 本地全文:下载
  • 作者:Carlo Agostoni ; Jean-Louis Bresson ; Susan Fairweather-Tait
  • 期刊名称:EFSA Journal
  • 印刷版ISSN:1831-4732
  • 出版年度:2010
  • 卷号:8
  • 期号:2
  • DOI:10.2903/j.efsa.2010.1430
  • 出版社:European Food Safety Authority (EFSA), Parma
  • 摘要:Following an application from Danone Baby Nutrition, submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of The Netherlands, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to Immunofortis® to naturally strengthen the baby’s immune system. The scope of the application was proposed to fall under a health claim referring to children’s development and health The Panel considered that the food constituent, Immunofortis®, a 9:1 mixture of short-chain galacto- and long-chain fructo-oligosaccharides, was sufficiently characterised. The target population consisted of infants who were not breastfed or who were partially breastfed and who were less than 12 months old. The Panel considered that a well-functioning immune system includes the initiation of appropriate adaptive immune responses and an appropriate defence against pathogens and was a beneficial physiological effect. In weighing the evidence, the Panel took into account that the one human intervention study investigating the effects of Immunofortis® on the incidence of atopic dermatitis and the overall cumulative incidence of infections had considerable limitations, that the evidence for an effect of Immunofortis® on the reduction of potentially pathogenic bacteria was inconsistent, that the evidence for an effect of Immunofortis® on immune function animal studies did not predict the occurrence of an effect in humans, and that the evidence presented in support of a biologically plausible mechanism by which Immunofortis® could exert the claimed effect was not convincing. The Panel concluded that the evidence provided was insufficient to establish a cause and effect relationship between the consumption of Immunofortis® and the claimed effect of initiation of appropriate immune responses including the defence against pathogens.
  • 关键词:Galacto-oligosaccharides; fructo-oligosaccharides; Immunofortis®; infections; allergy; infants; infant formula
国家哲学社会科学文献中心版权所有